In 2024, the global plasma fractionation market was valued at USD 29.76 billion, and projections anticipate growth at a compound annual growth rate of 6.5 % during the forecast window. Within that overarching expansion, the concentration of revenue, innovation and policy influence in a handful of countries—particularly the United States, Germany, China, and Japan—drives how the...